Testing a new medication for agitation in Alzheimer's disease

This study is testing a new medication called KarXT + KarX-EC to see if it can help reduce agitation and aggressive behavior in people with Alzheimer's disease. Agitation—such as restlessness, irritability, or aggressive outbursts—is a common and distressing symptom for people with Alzheimer's, and this medication is being studied as a potential treatment. Half of the participants will receive the new medication, and half will receive a placebo (a pill with no active ingredient) to compare how well the treatment works.

Agitation and aggression are serious problems for many people with Alzheimer's disease and can make their care more difficult and stressful. Current treatment options are limited, so researchers are testing this new medication to see if it offers a safer and more effective way to help manage these challenging behaviors.